The pharmaceutical business sector rose sharply, and many stocks such as Kaikai Industrial rose to the limit
Time of Update: 2022-11-26
【Pharmaceutical Network Pharmaceutical Stock Market】On November 17, the pharmaceutical business sector rose sharply, individual stocks, at 10:40, Kaikai Industry, First Pharmaceutical, Shuyu Civilian
The pharmaceutical industry performed well in the first quarter, with the added value increasing by 11.8% year-on-year
Time of Update: 2022-05-19
Among them, Tonghua Dongbao expects to achieve a net profit of 817 million yuan attributable to shareholders of listed companies in the first quarter, a year-on-year increase of 142.
Over 6 drug reviews since March
Time of Update: 2022-05-01
On March 3, NMPA information showed that Yangzijiang Pharmaceutical's sodium potassium magnesium sulfate oral solution and levofloxacin sodium chloride injection, which were reported as 3/4 generic drugs, were approved for marketing, which were deemed to have passed the consistency evaluation .
These two pharmaceutical companies have joined forces to launch new anti-tumor drug commercialization cooperation
Time of Update: 2022-03-07
Just recently, Baheal Pharma announced that it will "join hands" with Shanghai Yizhong, and the two sides will cooperate on the commercialization of Zisheng, an innovative tumor drug under Shanghai Yizhong, "Paclitaxel Polymeric Micellar for Injection" ("Paclitaxel Micellar" for short) .
Zisheng®, the "paclitaxel polymer micelle for injection" independently developed by Shanghai Yizhong, is a new dosage form of 2.
The development of the pharmaceutical equipment industry continues to improve, and a large number of pharmaceutical machine companies will benefit
Time of Update: 2022-01-22
9%, and a net profit of 165 million yuan, a year-on-year increase of 413.
On the whole, the leading companies represented by Chutian and Tofflon performed very well last year, and their net profit increased significantly .
The results of the sixth batch of centralized procurement of medicines were announced: the highest drop of insulin was over 70
Time of Update: 2021-12-03
89 yuan/piece, a decrease of 64%, and the proposed company is Ganli Pharmaceutical; and among the three generations of insulin, the lowest proposed bid price for meal insulin analogues is 19.
Huge market demand for China's pharmaceutical equipment industry in 2020 [Photos
Time of Update: 2021-09-14
Market analysis of chemical machinery equipment networkChemical machinery and equipmentPharmaceutical equipmentgrinder According to data released by the China Pharmaceutical Equipment Industry Association, the total industrial output value of the pharmaceutical equipment industry from 2015 to 2018 shows an overall growth trend.
Yangzijiang Pharmaceutical, the number one in China's pharmaceutical industry, was fined 764 million heavily for monopoly
Time of Update: 2021-07-09
Therefore, the State Administration of Market Supervision finally decided: to fine Yangzijiang Pharmaceutical in accordance with 3% of its 2018 sales .
Sudden! The general manager of a multinational pharmaceutical company in China has left his appointment
Time of Update: 2021-03-09
Sammy Karam, Abbott's senior vice president and head of emerging markets for the pharmaceutical business, announced the news to employees that Mr Kim would leave Abbott to seek other career opportunities, with the last working day on March 5.
The technological revolution in the field of pharmaceutical circulation will upend tradition
Time of Update: 2021-02-16
2017 is also a year of marketing model transformation, many pharmaceutical circulation enterprises (especially to do generic drug sales) set up their own sales control varieties team, from rough distribution and distribution to terminal customer service.
Roche PD-L1, a pharmaceutical speed reading agency, has won the termination of 260 million collaborations between four clinical drug companies in China
Time of Update: 2020-11-14
(Jiangxi Provincial Drug Administration) Part 2 after observation of 260 million two well-known pharmaceutical companies to terminate cooperation 7, Haisco issued a notice, wholly-owned subsidiary Sichuan Haisco on September 4 and Haitron Pharmaceuticals signed a "patent implementation license agreement and related agreements to terminate the agreement." After friendly consultations between the two sides, Sichuan Haisco transferred the original HC-1119 patented products to Haitron Pharmaceuticals, with a total transfer value of RMB260 million, to be paid in three installments.
How big is the out-of-hospital market where multinational pharmaceutical companies are coding
Time of Update: 2020-11-13
people pointed out the current development bottleneck of the off-hospital market, including: the out-of-hospital market volume is small, the retail industry bargaining power is enhanced, drug price increase is limited and so on.
Howson preempts Qilu! AstraZeneta's heavy sugar-lowering drug is under siege from domestic giants
Time of Update: 2020-10-28
figure 4: Declaration of shagritin film imitation listed enterprises Source: Minet MED2.0 China Drug Review Database Haussen's listing application, if successfully approved, will become the third (and as if reviewed), and Qilu pharmaceutical declaration time is late, the relevant acceptance number is currently being reviewed and approved.
What is the revenue of multinational pharmaceutical companies in the first half of 2020? Generally slowing down or slipping
Time of Update: 2020-09-11
For example, Bayer's second-quarter revenue fell 8.8 percent, citing two factors, one affected by COVID-19 and the other because China's volume-based procurement policy significantly reduced the price of the diabetes drug Acaposin.
Yangzijiang tamoxifen, Anaquzole first through the consistency evaluation
Time of Update: 2020-06-10
recently, Yangzijiang Pharmaceutical Group taxifen tablets (10mg), anaquzoltableta (1mg) two anti-tumor products (http:// the first by the imitation of pharmaceutical (http:// quality and effi